Retinoic acid and N-(4-hydroxy-phenyl) retinamide suppress growth of esophageal squamous carcinoma cell lines

Cancer Letters

Volumn 113, Issue 1-2, 1997, Pages 95-101

  Muller, Annegret ^a   Nakagawa, Hiroshi ^a   Rustgi, Anil K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cell growth; Esophageal cancer; Retinoids

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FENRETINIDE; KERATIN; RETINOIC ACID;

ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL STRUCTURE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SQUAMOUS CELL CARCINOMA;

EID: 0031586765     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04601-6     Document Type: Article

References (27)

1. [1] Sons, H.U. (1987) Etiology and epidemiology of carcinoma of the esophagus, Surg. Gynecol. Obstet., 165, 183-190.
2. [2] Jiang, W., Kahan, N., Tomira, N., Zhang, Y., Lu, S. and Weinstein, I.B. (1992) Amplification and expression of the human cyclin D gene in esophageal cancer, Cancer Res, 52, 2980-2983.
3. [3] Jiang, W., Zhang, Y.U., Kahn, S.M., Hollstein, M.C., Santella, R.M., Lu, S.H., Harris, C.C., Montesano, R. and Weinstein, B. (1993) Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 90, 9026-9030.
4. [4] Nakagawa, H., Zukerberg, L., Togawa, K., Meltzer, S.J., Nishihara, T. and Rustgi, A.K. (1995) Human cyclin D1 oncogene and esophageal squamous cell carcinoma, Cancer, 76, 541-549.
5. [5] Hollstein, M.C., Smits, A.M., Galiana, C., Yamasaki, H., Bos, J.L. and Mandard, A. et al. (1988) Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers, Cancer Res, 48, 5119-5123.
6. [6] Hollstein, M.C., Metcalf, R.A., Walsh, J.A., Montesano, R. and Harris, C.C. (1990) Frequent mutation of the p53 gene in human esophageal cancer, Proc. Natl. Acad. Sci. USA, 87, 9958-9961.
7. [7] Bennett, W.P., Wollstein, M.C., Metcalf, R.A., Walsh, J.A, He, A., Zhu, S.M. et al. (1992) p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res., 52, 6092-6097.
8. [8] Meltzer, S.J., Jing, Y. and Huang, Y. et al. (1991) Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction, Proc. Natl. Acad. Sci. USA, 88, 4976-4980.
9. [9] Hollstein, M.C., Peri, L., Mandard, A.M., Walsh, J.A., Montesano, R. and Metcalf, R.A. et al. (1991) Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations, Cancer Res., 51, 4102-4106.
10. [10] Mori, T., Miura, K., Aoki, T., Nishihara, T., Mori, S. and Nakamura, Y.(1994) Cancer Res., 54, 3396-3397.
11. [11] Liu, Q., Yan, Y.X., McClure, M., Nakagawa, H., Fujimura, F. and Rustgi, A.K. (1995) MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines, Oncogene, 10, 619-622.
12. [12] Stoner, G. and Rustgi, A.K. (1995) Biology of esophagus squamous cell carcinoma. In: Gastrointestinal Cancers: Biology, Diagnosis, and Therapy. Editor: A.K. Rustgi. Lippincott-Raven Press, pp. 141-148.
13. [13] Kapil, U., Srivastava, M. and Nayar, D. (1993) Vitamin A and esophageal cancer, Trop. Gastroenterol., 14, 87-90.
14. [14] Swaroop, V., Damle, S.R., Advani, S.H. and Desai, P.B. (1989) 'Nutrition and esophageal cancer, Semin. Surg. Oncol., 5, 370-372.
15. [15] Lotan, R. (1994) Suppression of squamous cell carcinoma growth and differentiation by retinoids, Cancer Res., 54, 1987s-1990s.
16. [16] Zou, C.P., Clifford, J.L., Xu, X.C., Sacks, P.G., Chambon, P., Hong, W.K. and Lotan, R. (1994) Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines, Cancer Res., 54, 5479-5487.
17. [17] Heyman, R.A., Mangelsdorf, D.J., Dyck, J.A., Stein, R.B., Eichele, G., Evans, R.M. and Thaller, C. (1992) 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor, Cell, 68, 397-406.
18. [18] Xu, X.C., Ro, J.Y., Lee, J.S., Shin, D.M., Kong, W.K. and Lotan, R. (1994) Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues, Cancer Res., 54, 3580-3587.
19. [19] Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol. Methods, 65, 55-63.
20. [20] Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248-254.
21. [21] Lotan, R. (1993) Retinoids and squamous cell differentiation. In: Retinoids in Oncology, pp. 43-72. Editors: W.K. Hong and R. Lotan, Marcel-Dekker, New York.
22. [22] DeLuca, L.M. (1991) Retinoids and their receptors in differentiation, embryogenesis and neoplasia, FASEB J., 5, 2924-2933.
23. [23] Jetten, A.M., Nervi, C. and Vollberg, T.M. (1992) Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids, J. Natl. Cancer Inst. Monogr., 13, 93-100.
24. [24] Lippman, S.M., Kessler, J.F. and Meyskens, F.L. Jr. (1987) Retinoids as preventive and therapeutic anticancer agents (part III). Cancer Treat. Rep., 71. 493-511.
25. [25] DiVinci, A., Geido, E., Infusini, E. ti and Giaretti, W. (1994) Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl) retinamide, Int. J. Cancer, 59, 422-426.
26. [26] Delia, D., Aiello, A., Lombardi, L., Pelicci, P.G., Grignani, F., Grignani, F., Formelli, F., Menard, S., Costs, A., Veronesi, U. and Pierotti, M.A. (1993) N-(4-Hydroxyphenyl) retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid, Cancer Res., 53, 6036-6041.
27. [27] Miller, W.H. Jr., Maerz, W.J., Kurie, J., Moy, D., Baselga, J., Lucas, D.A., Grippo, J.F., Masui, H. and Dmitrovsky, E. (1994) All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-α and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas, Differentiation, 55, 145-152.